Clinical Trial Update: TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating tumor-infiltrating lymphocyte (TIL) therapy in combination with checkpoint inhibitors for metastatic ovarian cancer has been comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• TIL therapy in combination with checkpoint inhibitors

Snippet

Sponsor: Inge Marie Svane | Conditions: Metastatic Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-22